PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Apr-2024 Veeva Launches AI Partner Program Veeva
18-Apr-2024 Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipeline Outrun Therapeutics
18-Apr-2024 Sanofi New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
18-Apr-2024 Polaroid Therapeutics Announces Strategic Hire: Markus Rothmaier Takes Helm of Research and Development Polaroid Therapeutics
18-Apr-2024 Likarda appoints Shelly Adams as Chief Commercial Officer Likarda
18-Apr-2024 Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy Cresset
18-Apr-2024 Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments Evotec SE
18-Apr-2024 CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 CureVac
18-Apr-2024 M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million M1 Kliniken AG
18-Apr-2024 Invitation: Straumann Group 2024 first-quarter sales report webcast Straumann Holding AG
18-Apr-2024 Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity Biophytis
18-Apr-2024 Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 Sartorius Stedim Biotech SA
18-Apr-2024 DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029 DocMorris AG
17-Apr-2024 Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon Lonza Group AG
17-Apr-2024 aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages aap Implantate AG
17-Apr-2024 DocMorris launches approx. CHF 200 million Convertible Bonds due 2029 DocMorris AG
17-Apr-2024 Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE
17-Apr-2024 Annual General Meeting of Kuros Biosciences approves all resolutions Kuros Biosciences AG
17-Apr-2024 DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH Defence Therapeutics Inc.
17-Apr-2024 Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE